Adenylosuccinate lyase (ADSL) is a pan-cancer prognostic and immune biomarker with distinct roles in hepatocellular carcinoma
{{output}}
Background: The role of ADSL in various types of cancer remains inadequately understood. We encompassed a comprehensive examination of the mechanistic features of ADSL and explored its viability as a broad-spectrum predictor for ... ...
